Patent · US Active

Substituted imidazo[1,2-a]pyrimidines and —pyridines

US8975265B2 · kind B2 · utility

3Cited by

0References

10Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Stuart Ince · Berlin, DE
Andrea Hägebarth · Berlin, DE
Oliver Politz · Panketal, DE
Roland Neuhaus · Berlin, DE
Ulf Bömer · Glienicke, DE
William Scott · Guilford, US

Key dates

Filing date	Jul 7, 2011
Grant date	Mar 10, 2015
Priority date	—
Expiry date	Jul 7, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F5/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I) which are effective inhibitors of the Pi3K/Akt pathway, processes for their production and their use as pharmaceuticals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.